US pharma supply chain consolidation hurts Indian firms

Domestic pharmaceutical majors selling generic medicines in the US are finding the going tough. Companies such as Dr Reddy’s Laboratories, Sun Pharmaceutical, Lupin and Ranbaxy striving to capitalise on opportunities created by pro-generic health care reforms in the US market are facing pricing pressure as the health care supply chain is undergoing consolidation.

Read Full Story>>